These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 3019586

  • 21. Identification of risk factors predisposing to the development of functional renal insufficiency during treatment with converting-enzyme inhibitors in chronic heart failure.
    Packer M.
    Cardiology; 1989; 76 Suppl 2():50-5. PubMed ID: 2670221
    [Abstract] [Full Text] [Related]

  • 22. Angiotensin-converting enzyme inhibitors and renal function in heart failure.
    Dietz R, Nagel F, Osterziel KJ.
    Am J Cardiol; 1992 Oct 08; 70(10):119C-125C. PubMed ID: 1329467
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Angiotensin converting enzyme inhibition and autoregulation of glomerular filtration.
    Plante GE, Chainey A, Sirois P, Devissaguet M.
    J Hypertens Suppl; 1988 Dec 08; 6(3):S69-73. PubMed ID: 3066878
    [Abstract] [Full Text] [Related]

  • 29. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
    Halperin JL, Faxon DP, Creager MA, Bass TA, Melidossian CD, Gavras H, Ryan TJ.
    Am J Cardiol; 1982 Nov 08; 50(5):967-72. PubMed ID: 6182786
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
    Townend JN, Doran J, Lote CJ, Davies MK.
    Br Heart J; 1995 May 08; 73(5):434-41. PubMed ID: 7786658
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH, Cody RJ.
    Clin Pharmacokinet; 1985 May 08; 10(5):377-91. PubMed ID: 2994938
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction).
    Schroten NF, Damman K, Hemmelder MH, Voors AA, Navis G, Gaillard CA, van Veldhuisen DJ, Van Gilst WH, Hillege HL.
    Am Heart J; 2015 May 08; 169(5):693-701.e3. PubMed ID: 25965717
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.